Filing Details
- Accession Number:
- 0001062993-15-006258
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-16 19:49:21
- Reporting Period:
- 2015-11-13
- Filing Date:
- 2015-11-16
- Accepted Time:
- 2015-11-16 19:49:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1355189 | Thomas Wegman | C/O Biospecifics Technologies Corp., 35 Wilbur Street Lynbrook NY 11563 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Disposition | 2015-11-13 | 24,015 | $52.56 | 150,807 | No | 4 | S | Direct | |
Common Stock, $0.001 Par Value | Disposition | 2015-11-16 | 3,136 | $51.46 | 147,671 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The selling price of $52.5635 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.80 to $53.50. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $51.4643 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.00 to $52.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.